Why LSTA? Lisata Therapeutics, Inc. Analysis, Price & AI Insights | Whystock
LSTA
$3.13+0.01 (+0.32%)
Market ClosedLast close May 1
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases.